Transforming CABG: Innovation at the Heart of Surgery
Coronary artery bypass grafting (CABG) is entering a new era. With the rise of minimally invasive and robotic-assisted procedures, advances in imaging, and growing clinical demand for precision and speed, the CABG device landscape is rapidly evolving. This exclusive analysis explores the key innovations, competitive shifts, and strategic opportunities redefining the future of cardiac surgery.
Key Highlights:
-
Global CABG market projected to grow from $9.39 billion (2024) to $12.20 billion (2029) at 5.4% CAGR
-
Analysis of on-pump vs. off-pump surgical trends and devices
-
Strategic imperatives: Value-based care, minimally invasive tech, and AI-guided imaging
-
Profiles of Key Players: Medtronic, Boston Scientific, Terumo, Getinge, Johnson & Johnson, and more
-
Regional insights for North America, Europe, APAC, LATAM, and MEA
Top 3 Growth Opportunities:
-
Minimally Invasive and Robotic CABG Procedures
-
Advanced Imaging and AI-Supported Surgical Planning
-
Strategic Collaborations in Surgical Robotics
Download Sample
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.
*$1,000 honorarium is subject to eligibility
